Table 5.

Associations of galectin-3 with ischaemic stroke risk, stratified by age

Model	N	Q1	Q2-Q4
Age < 64
A	489	Referent	2.4 (1.4, 4.1), P = 0.002
B	489	Referent	3.0 (1.6, 5.5), P < 0.001
C	443	Referent	1.9 (1.0, 3.8), P = 0.05
D	443	Referent	2.0 (1.0, 4.0), P = 0.06
Age 64+
A	984	Referent	1.1 (0.7, 1.7), P = 0.66
B	984	Referent	0.9 (0.6, 1.3), P = 0.46
C	919	Referent	0.8 (0.5, 1.3), P = 0.36
D	919	Referent	0.8 (0.5, 1.2), P = 0.26

Models: A, unadjusted; B, adjusted for age, sex, race, age × race; C, model B + Framingham stroke risk factors (diabetes, systolic blood pressure, use of any antihypertensive medications, left ventricular hypertrophy, history of coronary artery disease, atrial fibrillation); D, model C + income, education. N, total number of participants in the analysis; Q, quartile.